Chembio Diagnostic Systems
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Chembio Diagnostic Systems sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,751 sponsors by registered trial count).
Chembio Diagnostic Systems: 3 sponsored US clinical trials, none currently recruiting.
Chembio Diagnostic Systems sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is HIV Infections, with 2 trials.
Upper-quartile sponsor footprint
Chembio Diagnostic Systems sits in the upper quartile of the sponsor corpus (#3,661 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test
NCT01032902
Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid
NCT00636220
Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population
NCT00567749
Therapeutic Areas
How the Chembio Diagnostic Systems archive is shaped
3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: HIV Infections (2 trials), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.